Siltuximab receives positive CHMP opinion supporting approval in multicentric Castleman's disease March 25, 2014
Phase III trial of GSK's MAGE-A3 immunotherapeutic in NSCLC misses first co-primary endpoints March 21, 2014
Innate Pharma continues phase II trial of lirilumab in AML based on DSMB recommendation March 12, 2014
RSS